Taiwan · Delayed Price · Currency is TWD Gongwin Biopharm Holdings Statistics
Total Valuation
TPEX:6617 has a market cap or net worth of TWD 16.59 billion. The enterprise value is 15.23 billion.
| Market Cap | 16.59B |
| Enterprise Value | 15.23B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TPEX:6617 has 121.12 million shares outstanding. The number of shares has decreased by -2.82% in one year.
| Current Share Class | 121.12M |
| Shares Outstanding | 121.12M |
| Shares Change (YoY) | -2.82% |
| Shares Change (QoQ) | -0.97% |
| Owned by Insiders (%) | 24.61% |
| Owned by Institutions (%) | 0.04% |
| Float | 53.58M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 392.99 |
| PB Ratio | 7.13 |
| P/TBV Ratio | 7.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.19, with a Debt / Equity ratio of 0.06.
| Current Ratio | 8.19 |
| Quick Ratio | 7.29 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.76 |
| Interest Coverage | -59.05 |
Financial Efficiency
Return on equity (ROE) is -7.36% and return on invested capital (ROIC) is -5.98%.
| Return on Equity (ROE) | -7.36% |
| Return on Assets (ROA) | -5.65% |
| Return on Invested Capital (ROIC) | -5.98% |
| Return on Capital Employed (ROCE) | -9.91% |
| Weighted Average Cost of Capital (WACC) | 5.81% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.02 |
| Inventory Turnover | 3.84 |
Taxes
In the past 12 months, TPEX:6617 has paid 49,000 in taxes.
| Income Tax | 49,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.00% in the last 52 weeks. The beta is 0.29, so TPEX:6617's price volatility has been lower than the market average.
| Beta (5Y) | 0.29 |
| 52-Week Price Change | +37.00% |
| 50-Day Moving Average | 110.34 |
| 200-Day Moving Average | 84.39 |
| Relative Strength Index (RSI) | 61.38 |
| Average Volume (20 Days) | 1,140,596 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6617 had revenue of TWD 42.22 million and -164.52 million in losses. Loss per share was -1.35.
| Revenue | 42.22M |
| Gross Profit | 26.64M |
| Operating Income | -241.17M |
| Pretax Income | -176.12M |
| Net Income | -164.52M |
| EBITDA | -232.54M |
| EBIT | -241.17M |
| Loss Per Share | -1.35 |
Balance Sheet
The company has 1.51 billion in cash and 149.93 million in debt, with a net cash position of 1.36 billion or 11.24 per share.
| Cash & Cash Equivalents | 1.51B |
| Total Debt | 149.93M |
| Net Cash | 1.36B |
| Net Cash Per Share | 11.24 |
| Equity (Book Value) | 2.33B |
| Book Value Per Share | 19.21 |
| Working Capital | 1.51B |
Cash Flow
In the last 12 months, operating cash flow was -195.87 million and capital expenditures -2.41 million, giving a free cash flow of -198.28 million.
| Operating Cash Flow | -195.87M |
| Capital Expenditures | -2.41M |
| Depreciation & Amortization | 8.63M |
| Net Borrowing | 26.78M |
| Free Cash Flow | -198.28M |
| FCF Per Share | -1.64 |
Margins
| Gross Margin | 63.09% |
| Operating Margin | -571.17% |
| Pretax Margin | -417.11% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TPEX:6617 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.82% |
| Shareholder Yield | 2.82% |
| Earnings Yield | -0.99% |
| FCF Yield | -1.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TPEX:6617 has an Altman Z-Score of 18.8 and a Piotroski F-Score of 2.
| Altman Z-Score | 18.8 |
| Piotroski F-Score | 2 |